Found 0 matching trials
Testing Olaparib and Temozolomide Versus the Usual Treatment for Uterine Leiomyosarcoma After Chemotherapy Has Stopped Working PHASE2 This phase II/III trial compares the effect of the combination treatment wi...
Show More Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Learn More & Join Trial
GRETeL: Tumor Response to Standard Radiotherapy and TMZ Patients With GBM N/A The purpose of this study is to better define longitudinal genomic alterati...
Show More Location
The Preston Robert Tisch Brain Tumor Center at Duke University
Learn More & Join Trial
Cilengitide and Metronomic Temozolomide for Relapsed or Refractory High Grade Gliomas or Diffuse Intrinsic Pontine Gliomas in Children and Adolescents PHASE2 The primary objective of this study is to evaluate the efficacy of a combin...
Show More Location
University Children“s Hospital
Learn More & Join Trial
Temozolomide in Treating Women With Advanced Breast Cancer PHASE2 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Show More Location
Christie Hospital N.H.S. Trust
Learn More & Join Trial
Analyzing Pulsed Reduced Dose Radiotherapy in Upfront Glioblastoma PHASE2 The primary protocol objective is to assess the impact of substituting puls...
Show More Status
Active Not Recruiting
Location
Medical College of Wisconsin
Learn More & Join Trial
Dendritic Cell-Based Tumor Vaccine Adjuvant Immunotherapy of Human Glioblastoma Multiforme (WHO Grade IV Gliomas) PHASE2 Purposes:
The purpose of this phase-II clinical trial is to determine whet...
Show More Location
China Medical University Hospital
Learn More & Join Trial
Combination of Lanreotide Autogel 120mg and Temozolomide in Progressive GEP-NET PHASE2 The purpose of the study is to evaluate the efficacy and tolerability of th...
Show More Location
Vienna General Hospital
Learn More & Join Trial
A Dose Finding Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination With Standard of Care and in Recurrent Glioblastoma as a Single Agent. PHASE1 A Dose Finding Study of \[177Lu\]Lu-DOTA-TATE in Newly Diagnosed Glioblasto...
Show More Status
Active Not Recruiting
Location
Col Uni Med Center New York Presby
Learn More & Join Trial
PH I Addition of Farnesyl Transferase Inhibitor to Temozolomide for Pts w Gr 3 & 4 Malignant Gliomas PHASE1 Objectives:
To determine maximum tolerated dose of farnesyl transferase in...
Show More Location
Duke University Health System
Learn More & Join Trial
Survivin-Targeted Dendritic Cell (DC) Cell Injection for Newly Diagnosed Glioblastoma PHASE2 The overall objective of this study is to preliminarily evaluate the effica...
Show More Location
Multiple Locations
Learn More & Join Trial